Development and Validation of a Stability‐Indicating LC Method for the Determination of Empagliflozin‐Related Substances With Sensitivity Profiling and Robustness Assessment Using Analytical Quality by Design Principles

Documenti analoghi

• Correction to “Development and Validation of a Stability‐Indicating LC Method for the Determination of Empagliflozin‐Related Substances With Sensitivity Profiling and Robustness Assessment Using Analytical Quality by Design Principles”
  Pubblicazione: (2026)
• Development and Validation of a Stability‐Indicating Liquid Chromatographic Method for Darolutamide and Its Degradation Impurities and Analytical Quality by Design‐Based Robustness Assessment
  di: Vidya Sagara Reddy Evuri, et al.
  Pubblicazione: (2025)
• Ultra‐Sensitive and Green LC–MS/MS Method for Trace‐Level Determination of Nitrosamine Drug Substance‐Related Impurities in the Anti‐Diuretic Drug Furosemide
  di: Santhosh Kumar Ettaboina, et al.
  Pubblicazione: (2026)
• Determination and Quantification of Related Impurity Substances in Elvitegravir Drug Substance by Full Factorial Design Evaluated Liquid Chromatography Method
  di: Jythesh Kumar Srinilayam Rajasekharannair, et al.
  Pubblicazione: (2024)
• Development and Optimization of a Sensitive LC–MS/MS Method for the Quantification of N‐Nitroso Bisoprolol in Pharmaceutical Formulations
  di: Rajesh Damarapurapu, et al.
  Pubblicazione: (2026)